Phone (Mobile)
+1 646 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(510) 204-7200
Phone (HQ)
❅❅❅❅❅@xoma.com
❅❅❅❅❅@gmail.com
Office Address (HQ)
2200 Powell St Ste 310, Emeryville, California, 94608, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Brad Sitko
According to Datanyze information, these are Brad Sitko's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 646 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(510) 204-7200
Phone (HQ)
❅❅❅❅❅@xoma.com
❅❅❅❅❅@gmail.com
Office Address (HQ)
2200 Powell St Ste 310, Emeryville, California, 94608, United States
Office Address (HQ)
Brad Sitko works as a Chief Investment Officer at XOMA Royalty, which is a Business Services company with an estimated 13 employees; and founded in 1981. They are part of the Finance team within the Finance Department and their management level is C-Level. Brad graduated from Columbia Business School and is currently based in Emeryville, United States. They used to work at RTW Logistics and Jixing Pharmaceuticals and have used the following emails: @xoma.com, @mtspartners.com, @datamonitor.com.
Wow! Brad seems fun! 😎
Brad Sitko's career began less then a year ago. Prior to joining XOMA Royalty, Brad worked at 10 companies.
RTW Investments ICAV
Director (Board Member)
Managing Director, Strategic Finance
Chief Financial Officer
Vice President, Finance & Operations Corporate Development Acting Chief Financial Officer & Chief Operating Officer
Investment Banking Director, Healthcare
Worldwide Strategic Planning & Innovation Associate
Business Development Portfolio & Decision Analysis Associate (Pda)
Consultant
Healthcare Consulting & Strategic Insight Analyst
Lobeman Group
Director, Sales & Marketing
Bachelor of Arts
University of Pennsylvania
Masters of Business Administration
Columbia Business School
XOMA Royalty
2200 Powell St Ste 310, Emeryville, California, 94608, United States
13
$9.8 M
Business Services, Research & Development
Get Full Profile Access
Ice Breakers
Imagine you could know all about XOMA Royalty - Brad Sitko’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Brad’s company in the news
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
December 2, 2024
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
November 7, 2024
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
October 22, 2024
See more
Insights to Break the Ice
In your first interaction
Brad’s CEO is Owen Hughes
Brad is located in United States
Work Colleague
See Brad Sitko's coworkers out of XOMA Royalty's 13 employees